These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 14532152)

  • 1. Angiogenesis as a target in rheumatoid arthritis.
    Koch AE
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii60-7. PubMed ID: 14532152
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of angiogenesis in rheumatoid arthritis: recent developments.
    Koch AE
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i65-71. PubMed ID: 11053092
    [No Abstract]   [Full Text] [Related]  

  • 3. Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.
    Plum SM; Park EJ; Strawn SJ; Moore EG; Sidor CF; Fogler WE
    BMC Musculoskelet Disord; 2009 May; 10():46. PubMed ID: 19409094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of angiogenesis: ready for prime time?
    Maracle CX; Tas SW
    Best Pract Res Clin Rheumatol; 2014 Aug; 28(4):637-49. PubMed ID: 25481555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of angiogenic factors in rheumatoid arthritis.
    Azizi G; Boghozian R; Mirshafiey A
    Int J Rheum Dis; 2014 May; 17(4):369-83. PubMed ID: 24467605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vasculature in rheumatoid arthritis: cause or consequence?
    Paleolog EM
    Int J Exp Pathol; 2009 Jun; 90(3):249-61. PubMed ID: 19563609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tripterygium wilfordii Inhibiting Angiogenesis for Rheumatoid Arthritis Treatment.
    Zhang W; Li F; Gao W
    J Natl Med Assoc; 2017 Summer; 109(2):142-148. PubMed ID: 28599756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood vessels, a potential therapeutic target in rheumatoid arthritis?
    Semerano L; Clavel G; Assier E; Denys A; Boissier MC
    Joint Bone Spine; 2011 Mar; 78(2):118-23. PubMed ID: 20851025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractalkine in rheumatoid arthritis: a review to date.
    Murphy G; Caplice N; Molloy M
    Rheumatology (Oxford); 2008 Oct; 47(10):1446-51. PubMed ID: 18495821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endostatin in orthopedics.
    McMahon MS
    Orthopedics; 2012 Sep; 35(9):736-8. PubMed ID: 22955381
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights in synovial angiogenesis.
    Szekanecz Z; Besenyei T; Paragh G; Koch AE
    Joint Bone Spine; 2010 Jan; 77(1):13-9. PubMed ID: 20022538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting rheumatoid tenosynovial angiogenesis with cytokine inhibitors.
    Jain A; Kiriakidis S; Brennan F; Sandison A; Paleolog E; Nanchahal J
    Clin Orthop Relat Res; 2006 May; 446():268-77. PubMed ID: 16456308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis as a potential treatment strategy for rheumatoid arthritis.
    Wang Y; Wu H; Deng R
    Eur J Pharmacol; 2021 Nov; 910():174500. PubMed ID: 34509462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating angiogenesis: more vs less.
    Sivakumar B; Harry LE; Paleolog EM
    JAMA; 2004 Aug; 292(8):972-7. PubMed ID: 15328330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting synovial neoangiogenesis in rheumatoid arthritis.
    Leblond A; Allanore Y; Avouac J
    Autoimmun Rev; 2017 Jun; 16(6):594-601. PubMed ID: 28414154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of evidence for inhibition of angiogenesis as a central mechanism of the antiarthritic effect of methotrexate.
    Fiehn C; Wunder A; Krienke S; Max R; Ho AD; Moehler T
    Rheumatol Int; 2005 Mar; 25(2):108-13. PubMed ID: 14618373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis.
    Firestein GS
    J Clin Invest; 1999 Jan; 103(1):3-4. PubMed ID: 9884327
    [No Abstract]   [Full Text] [Related]  

  • 18. [Synovial angiogenesis].
    Lioté F
    Rev Prat; 1993 Nov; 43(17):2239-45. PubMed ID: 7511830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in rheumatoid arthritis.
    Maruotti N; Cantatore FP; Crivellato E; Vacca A; Ribatti D
    Histol Histopathol; 2006 May; 21(5):557-66. PubMed ID: 16493585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models.
    Lee JD; Huh JE; Jeon G; Yang HR; Woo HS; Choi DY; Park DS
    Int Immunopharmacol; 2009 Mar; 9(3):268-76. PubMed ID: 19111632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.